机构：[1]Department of Nuclear Medicine, Beijing Anzhen Hospital, Capital Medical University, Beijing, China[2]Department of Nuclear Medicine, Cardiovascular Institute and Fu Wai Hospital, Chinese Academy of Medical Sciences, Beijing, China[3]Key Laboratory of Radiopharmaceuticals, Ministry of Education, College of Chemistry, Beijing Normal University, Beijing, China[4]PET Center, Xuanwu Hospital of Capital University of Medical Sciences, Beijing, China首都医科大学宣武医院[5]Center for Molecular Imaging and Translational Medicine, School of Public Health, Xiamen University, Xiamen, China
出处：
ISSN：
基金：
This study was financially supported by the National Natural Science Foundation of China (81301251, 81271613).
第一作者机构：[1]Department of Nuclear Medicine, Beijing Anzhen Hospital, Capital Medical University, Beijing, China
推荐引用方式(GB/T 7714)：
Tiantian Mou,Zuoquan Zhao,Xianzhong Zhang,et al.Synthesis and Biological Evaluation of new F-18-labeled Pyridaben Analogues for PET Myocardial Perfusion Imaging[J].JOURNAL OF NUCLEAR MEDICINE.2015,56(3):
APA：
Tiantian Mou,Zuoquan Zhao,Xianzhong Zhang,Qian Wang,Wei Fang...&Cheng Peng.(2015).Synthesis and Biological Evaluation of new F-18-labeled Pyridaben Analogues for PET Myocardial Perfusion Imaging.JOURNAL OF NUCLEAR MEDICINE,56,(3)
MLA：
Tiantian Mou,et al."Synthesis and Biological Evaluation of new F-18-labeled Pyridaben Analogues for PET Myocardial Perfusion Imaging".JOURNAL OF NUCLEAR MEDICINE 56..3(2015)
医学